A genome-wide investigation of SNPs and CNVs in schizophrenia.
- Authors
- Need, Anna C; Ge, Dongliang; Weale, Michael E; Maia, Jessica; Feng, Sheng; Heinzen, Erin L; Shianna, Kevin V; Yoon, Woohyun; KasperaviciΕ«te, Dalia; Gennarelli, Massimo; Strittmatter, Warren J; Bonvicini, Cristian; Rossi, Giuseppe; Jayathilake, Karu; Cola, Philip A; McEvoy, Joseph P; Keefe, Richard S E; Fisher, Elizabeth M C; St Jean, Pamela L; Giegling, Ina; Hartmann, Annette M; MΓΆller, Hans-JΓΌrgen; Ruppert, Andreas; Fraser, Gillian; Crombie, Caroline; Middleton, Lefkos T; St Clair, David; Roses, Allen D; Muglia, Pierandrea; Francks, Clyde; Rujescu, Dan; Meltzer, Herbert Y; Goldstein, David B
- Year
- 2009
- Journal
- PLoS genetics
- PMID
- 19197363
- DOI
- 10.1371/journal.pgen.1000373
- PMCID
- PMC2631150
We report a genome-wide assessment of single nucleotide polymorphisms (SNPs) and copy number variants (CNVs) in schizophrenia. We investigated SNPs using 871 patients and 863 controls, following up the top hits in four independent cohorts comprising 1,460 patients and 12,995 controls, all of European origin. We found no genome-wide significant associations, nor could we provide support for any previously reported candidate gene or genome-wide associations. We went on to examine CNVs using a subset of 1,013 cases and 1,084 controls of European ancestry, and a further set of 60 cases and 64 controls of African ancestry. We found that eight cases and zero controls carried deletions greater than 2 Mb, of which two, at 8p22 and 16p13.11-p12.4, are newly reported here. A further evaluation of 1,378 controls identified no deletions greater than 2 Mb, suggesting a high prior probability of disease involvement when such deletions are observed in cases. We also provide further evidence for some smaller, previously reported, schizophrenia-associated CNVs, such as those in NRXN1 and APBA2. We could not provide strong support for the hypothesis that schizophrenia patients have a significantly greater "load" of large (>100 kb), rare CNVs, nor could we find common CNVs that associate with schizophrenia. Finally, we did not provide support for the suggestion that schizophrenia-associated CNVs may preferentially disrupt genes in neurodevelopmental pathways. Collectively, these analyses provide the first integrated study of SNPs and CNVs in schizophrenia and support the emerging view that rare deleterious variants may be more important in schizophrenia predisposition than common polymorphisms. While our analyses do not suggest that implicated CNVs impinge on particular key pathways, we do support the contribution of specific genomic regions in schizophrenia, presumably due to recurrent mutation. On balance, these data suggest that very few schizophrenia patients share identical genomic causation, potentially complicating efforts to personalize treatment regimens.
Novel >2 Mb deletions found in schizophrenia cases.Duplications and smaller deletions in region not shown. The chromosome 8 region is deleted in a single Munich patient. The chromosome 8 region is deleted in a patient from Aberdeen and has overlapping, smaller deletions in a patient from Munich and an African American patient. (Adapted from UCSC browser: http://genome.ucsc.edu).
No entities extracted from this document yet.
| Filename | Size | Added | |
|---|---|---|---|
| 19197363.pdf | 403401 bytes | 2026-05-15 | View |
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Circular RNAs in neurological conditions - computational identification, functional validation, and potential clinical applications. | Hatzimanolis O et al. | β | 2025 | β |
| Identification of key genes and pathways in schizophrenia: a bioinformatics analysis based on GWAS and GEO. | Shokrgozar A et al. | β | 2025 | β |
| Novel variants in ARID1B, SPSB1, and RAET1-AS shape genetic susceptibility and protection in systemic lupus erythematosus and lupus nephritis. | Chen HY et al. | β | 2025 | β |
| Translating Molecular Psychiatry: From Biomarkers to Personalized Therapies-A Narrative Review. | Capatina TF et al. | β | 2025 | β |
| Copy number deletion of PLA2G4A affects the susceptibility and clinical phenotypes of schizophrenia. | Gao Z et al. | β | 2024 | β |
| Schizophrenia, a disease of impaired dynamic metabolic flexibility: A new mechanistic framework. | Sarnyai Z et al. | β | 2024 | β |
| Heritability of amygdala reactivity to angry faces and its replicable association with the schizophrenia risk locus of <i>miR-137</i>. | Quarto T et al. | β | 2023 | β |
| Role of cryptic rearrangements of human chromosomes in the aetiology of schizophrenia. | Jurisova L et al. | β | 2023 | β |
| Bioinformatics and network-based approaches for determining pathways, signature molecules, and drug substances connected to genetic basis of schizophrenia etiology. | Khan U et al. | β | 2022 | β |
| Investigation of accelerated epigenetic aging in individuals suffering from schizophrenia in the context of lifetime suicide attempt. | Jeremian R et al. | β | 2022 | β |
| Sex-specific involvement of the Notch-JAG pathway in social recognition. | Jaaro-Peled H et al. | β | 2022 | β |
| Synapse Formation and Function Across Species: Ancient Roles for CCP, CUB, and TSP-1 Structural Domains. | GonzΓ‘lez-Calvo I et al. | β | 2022 | β |
| A comprehensive analysis of SNPs and CNVs identifies novel markers associated with disease outcomes in colorectal cancer. | Yu Y et al. | β | 2021 | β |
| Convergent genomic and pharmacological evidence of PI3K/GSK3 signaling alterations in neurons from schizophrenia patients. | Stertz L et al. | β | 2021 | β |
| Genome-Wide Association Analysis of Neonatal White Matter Microstructure. | Zhang J et al. | β | 2021 | β |
| Neurexins in autism and schizophrenia-a review of patient mutations, mouse models and potential future directions. | Tromp A et al. | β | 2021 | β |
| NRXN1Ξ±<sup>+/-</sup> is associated with increased excitability in ASD iPSC-derived neurons. | Avazzadeh S et al. | β | 2021 | β |
| The interaction of ASAH1 and NGF gene involving in neurotrophin signaling pathway contributes to schizophrenia susceptibility and psychopathology. | Su Y et al. | β | 2021 | β |
| A logical relationship for schizophrenia, bipolar, and major depressive disorder. Part 1: Evidence from chromosome 1 high density association screen. | Zhang Z et al. | β | 2020 | β |
| Analyzing Metabolomics Data for Environmental Health and Exposome Research. | Cai Y et al. | β | 2020 | β |
| Association between a <i>TCF4</i> Polymorphism and Susceptibility to Schizophrenia. | Gao JY et al. | β | 2020 | β |
| A Variation in FGF14 Is Associated with Downbeat Nystagmus in a Genome-Wide Association Study. | Strupp M et al. | β | 2020 | β |
| Control of craniofacial and brain development by Cullin3-RING ubiquitin ligases: Lessons from human disease genetics. | Asmar AJ et al. | β | 2020 | β |
| Genome-wide association study for circulating fibroblast growth factor 21 and 23. | Chuang GT et al. | β | 2020 | β |
| Phenotypic spectrum of NRXN1 mono- and bi-allelic deficiency: A systematic review. | Castronovo P et al. | β | 2020 | β |
| Targeted exon sequencing in deceased schizophrenia patients in Denmark. | Espregueira Themudo G et al. | β | 2020 | β |
| A comprehensive screening of copy number variability in dementia with Lewy bodies. | Kun-Rodrigues C et al. | β | 2019 | β |
| Chromatin Immunoprecipitation Techniques in Neuropsychiatric Research. | Bartlett AA et al. | β | 2019 | β |
| Genetic insights and neurobiological implications from NRXN1 in neuropsychiatric disorders. | Hu Z et al. | β | 2019 | β |
| GWAS of Behavioral Traits. | Mehta D et al. | β | 2019 | β |
| Increased Ca<sup>2+</sup> signaling in <i>NRXN1Ξ±</i><sup><i>+/-</i></sup> neurons derived from ASD induced pluripotent stem cells. | Avazzadeh S et al. | β | 2019 | β |
| Integrating Clinical Data and Imputed Transcriptome from GWAS to Uncover Complex Disease Subtypes: Applications in Psychiatry and Cardiology. | Yin L et al. | β | 2019 | β |
| SNP Variation of <i>RELN</i> Gene and Schizophrenia in a Chinese Population: A Hospital-Based Case-Control Study. | Luo X et al. | β | 2019 | β |
| Unravelling the genetic basis of schizophrenia and bipolar disorder with GWAS: A systematic review. | Prata DP et al. | β | 2019 | β |
| Wnt/Ξ²-catenin signaling in brain development and mental disorders: keeping TCF7L2 in mind. | Bem J et al. | β | 2019 | β |
| A genome-wide association study of early gamma-band response in a schizophrenia case-control sample. | Konte B et al. | β | 2018 | β |
| A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme. | Magri C et al. | β | 2018 | β |
| A novel relationship for schizophrenia, bipolar and major depressive disorder Part 3: Evidence from chromosome 3 high density association screen. | Chen X et al. | β | 2018 | β |
| Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression. | Culverhouse RC et al. | β | 2018 | β |
| Copy Number Variations in Adult-onset Neuropsychiatric Diseases. | Lew AR et al. | β | 2018 | β |
| Gene polymorphisms of DISC1 is associated with schizophrenia: Evidence from a meta-analysis. | Wang HY et al. | β | 2018 | β |
| Genome-Wide Association Study in Vestibular Neuritis: Involvement of the Host Factor for HSV-1 Replication. | Rujescu D et al. | β | 2018 | β |
| Mosaic Brain Aneuploidy in Mental Illnesses: An Association of Low-level Post-zygotic Aneuploidy with Schizophrenia and Comorbid Psychiatric Disorders. | Yurov YB et al. | β | 2018 | β |
| Werner syndrome (WRN) gene variants and their association with altered function and age-associated diseases. | Lebel M et al. | β | 2018 | β |
| Analysis of differential gene expression mediated by clozapine in human postmortem brains. | Lee BJ et al. | β | 2017 | β |
| A novel relationship for schizophrenia, bipolar and major depressive disorder Part 5: a hint from chromosome 5 high density association screen. | Chen X et al. | β | 2017 | β |
| A Novel Relationship for Schizophrenia, Bipolar, and Major Depressive Disorder. Part 8: a Hint from Chromosome 8 High Density Association Screen. | Chen X et al. | β | 2017 | β |
| A prenatal diagnosis of mosaic trisomy 5 reveals a postnatal complete uniparental disomy of chromosome 5 with multiple congenital anomalies. | Reittinger AM et al. | β | 2017 | β |
| Detection and validation of structural variations in bovine whole-genome sequence data. | Chen L et al. | β | 2017 | β |
| Emerging Synaptic Molecules as Candidates in the Etiology of Neurological Disorders. | Torres VI et al. | β | 2017 | β |
| Functional implications of Neandertal introgression in modern humans. | Dannemann M et al. | β | 2017 | β |
| Genome-Wide Association of Copy Number Polymorphisms and Kidney Function. | Li M et al. | β | 2017 | β |
| Impacts of Neanderthal-Introgressed Sequences on the Landscape of Human Gene Expression. | McCoy RC et al. | β | 2017 | β |
| Intracellular Fibroblast Growth Factor 14: Emerging Risk Factor for Brain Disorders. | Di Re J et al. | β | 2017 | β |
| NDE1 and NDEL1 from genes to (mal)functions: parallel but distinct roles impacting on neurodevelopmental disorders and psychiatric illness. | Bradshaw NJ et al. | β | 2017 | β |
| No genetic association between A118G polymorphism of ΞΌ-opioid receptor gene and schizophrenia and bipolar disorders. | Yazdani S et al. | β | 2017 | β |
| Potential Value of Genomic Copy Number Variations in Schizophrenia. | Zhuo C et al. | β | 2017 | β |
| PPARgamma agonists rescue increased phosphorylation of FGF14 at S226 in the Tg2576 mouse model of Alzheimer's disease. | Hsu WJ et al. | β | 2017 | β |
| Shared atypical default mode and salience network functional connectivity between autism and schizophrenia. | Chen H et al. | β | 2017 | β |
| The Correlation-Base-Selection Algorithm for Diagnostic Schizophrenia Based on Blood-Based Gene Expression Signatures. | Zhang H et al. | β | 2017 | β |
| A comprehensive analysis of NDST3 for schizophrenia and bipolar disorder in Han Chinese. | Zhang C et al. | β | 2016 | β |
| A Genome Wide Study of Copy Number Variation Associated with Nasopharyngeal Carcinoma in Malaysian Chinese Identifies CNVs at 11q14.3 and 6p21.3 as Candidate Loci. | Low JS et al. | β | 2016 | β |
| A pilot study on commonality and specificity of copy number variants in schizophrenia and bipolar disorder. | Chen J et al. | β | 2016 | β |
| Clinical and Neurobiological Relevance of Current Animal Models of Autism Spectrum Disorders. | Kim KC et al. | β | 2016 | β |
| Fibroblast Growth Factor 14 Modulates the Neurogenesis of Granule Neurons in the Adult Dentate Gyrus. | Alshammari MA et al. | β | 2016 | β |
| From Linkage Studies to Epigenetics: What We Know and What We Need to Know in the Neurobiology of Schizophrenia. | Cariaga-Martinez A et al. | β | 2016 | β |
| Patterns of genic intolerance of rare copy number variation in 59,898 human exomes. | Ruderfer DM et al. | β | 2016 | β |
| Association of microRNA biogenesis pathway gene variants and alcohol dependence risk. | Gedik H et al. | β | 2015 | β |
| Candidate gene-environment interaction research: reflections and recommendations. | Dick DM et al. | β | 2015 | β |
| Copy Number Variations in DISC1 and DISC1-Interacting Partners in Major Mental Illness. | Johnstone M et al. | β | 2015 | β |
| Expression analysis in a rat psychosis model identifies novel candidate genes validated in a large case-control sample of schizophrenia. | Ingason A et al. | β | 2015 | β |
| Genetic studies of schizophrenia: an update. | Chen J et al. | β | 2015 | β |
| Genomic analysis identifies candidate pathogenic variants in 9 of 18 patients with unexplained West syndrome. | Hino-Fukuyo N et al. | β | 2015 | β |
| Identification and functional studies of regulatory variants responsible for the association of <i>NRG3</i> with a delusion phenotype in schizophrenia. | ZeledΓ³n M et al. | β | 2015 | β |
| I-GSEA4GWAS v2: a web server for functional analysis of SNPs in trait-associated pathways identified from genome-wide association study. | Zhang K et al. | β | 2015 | β |
| Loci with genome-wide associations with schizophrenia in the Han Chinese population. | Li Z et al. | β | 2015 | β |
| S-SCAM, a rare copy number variation gene, induces schizophrenia-related endophenotypes in transgenic mouse model. | Zhang N et al. | β | 2015 | β |
| The deubiquitinating enzyme USP46 regulates AMPA receptor ubiquitination and trafficking. | Huo Y et al. | β | 2015 | β |
| The genetics of neuropsychiatric diseases: looking in and beyond the exome. | Heinzen EL et al. | β | 2015 | β |
| The genomic load of deleterious mutations: relevance to death in infancy and childhood. | Morris JA | β | 2015 | β |
| ADAMTS-12: a multifaced metalloproteinase in arthritis and inflammation. | Wei J et al. | β | 2014 | β |
| A genome-wide association analysis of a broad psychosis phenotype identifies three loci for further investigation. | Psychosis Endophenotypes International Consortium et al. | β | 2014 | β |
| A Likelihood-Based Framework for Association Analysis of Allele-Specific Copy Numbers. | Hu YJ et al. | β | 2014 | β |
| Analysis of the cumulative effect of schizophrenia-related single nucleotide polymorphisms. | Lozano R et al. | β | 2014 | β |
| Association study identifying a new susceptibility gene (AUTS2) for schizophrenia. | Zhang B et al. | β | 2014 | β |
| Chemical modulation of mutant mGlu1 receptors derived from deleterious GRM1 mutations found in schizophrenics. | Cho HP et al. | β | 2014 | β |
| CNVs in Epilepsy. | Mefford HC | β | 2014 | β |
| Combined analysis of exon splicing and genome wide polymorphism data predict schizophrenia risk loci. | Oldmeadow C et al. | β | 2014 | β |
| Copy number variant study of bipolar disorder in Canadian and UK populations implicates synaptic genes. | Noor A et al. | β | 2014 | β |
| Copy number variation distribution in six monozygotic twin pairs discordant for schizophrenia. | Castellani CA et al. | β | 2014 | β |
| Copy number variation in bronchopulmonary dysplasia. | Hoffmann TJ et al. | β | 2014 | β |
| Evolutionary conservation in genes underlying human psychiatric disorders. | Ogawa LM et al. | β | 2014 | β |
| Gene Γ environment interaction studies have not properly controlled for potential confounders: the problem and the (simple) solution. | Keller MC | β | 2014 | β |
| Genome-wide study of association and interaction with maternal cytomegalovirus infection suggests new schizophrenia loci. | BΓΈrglum AD et al. | β | 2014 | β |
| Heat shock alters the expression of schizophrenia and autism candidate genes in an induced pluripotent stem cell model of the human telencephalon. | Lin M et al. | β | 2014 | β |
| High rate of disease-related copy number variations in childhood onset schizophrenia. | Ahn K et al. | β | 2014 | β |
| Insertion-deletions burden in copy number polymorphisms of the Tibetan population. | Veerappa AM et al. | β | 2014 | β |
| Integrative biological analysis for neuropsychopharmacology. | Emmett MR et al. | β | 2014 | β |
| Low-Frequency Copy-Number Variants and General Cognitive Ability: No Evidence of Association. | Kirkpatrick RM et al. | β | 2014 | β |
| No association between NRG1 and ErbB4 genes and psychopathological symptoms of schizophrenia. | Tosato S et al. | β | 2014 | β |
| Novel treatment strategies for schizophrenia from improved understanding of genetic risk. | Morris BJ et al. | β | 2014 | β |
| On the association of common and rare genetic variation influencing body mass index: a combined SNP and CNV analysis. | Peterson RE et al. | β | 2014 | β |
| Pharmacogenetics of second-generation antipsychotics. | Brennan MD | β | 2014 | β |
| Protein interaction network of alternatively spliced isoforms from brain links genetic risk factors for autism. | Corominas R et al. | β | 2014 | β |
| Risk genes for schizophrenia: translational opportunities for drug discovery. | Winchester CL et al. | β | 2014 | β |
| Schizophrenia genetics comes of age. | Need AC et al. | β | 2014 | β |
| SIRPB1 copy-number polymorphism as candidate quantitative trait locus for impulsive-disinhibited personality. | Laplana M et al. | β | 2014 | β |
| The genetic architecture of neurodevelopmental disorders | Mitchell KJ | β | 2014 | β |
| The genetics of microdeletion and microduplication syndromes: an update. | Watson CT et al. | β | 2014 | β |
| Where now for schizophrenia research? | Nutt DJ et al. | β | 2014 | β |
| A genome-wide investigation of copy number variation in patients with sporadic brain arteriovenous malformation. | Bendjilali N et al. | β | 2013 | β |
| Analysis of common genetic variants identifies RELN as a risk gene for schizophrenia in Chinese population. | Li M et al. | β | 2013 | β |
| A population-based association study of 2q32.3 and 8q21.3 loci with schizophrenia in Han Chinese. | Guan F et al. | β | 2013 | β |
| Association study of OPRM1 polymorphisms with Schizophrenia in Han Chinese population. | Ding S et al. | β | 2013 | β |
| Autism genetics. | Persico AM et al. | β | 2013 | β |
| Both rare and de novo copy number variants are prevalent in agenesis of the corpus callosum but not in cerebellar hypoplasia or polymicrogyria. | Sajan SA et al. | β | 2013 | β |
| Copy number variants are frequent in genetic generalized epilepsy with intellectual disability. | Mullen SA et al. | β | 2013 | β |
| Developmental delays and reduced pup ultrasonic vocalizations but normal sociability in mice lacking the postsynaptic cell adhesion protein neuroligin2. | WΓΆhr M et al. | β | 2013 | β |
| Differential topochemistry of three cationic amino acid transporter proteins, hCAT1, hCAT2 and hCAT3, in the adult human brain. | JΓ€ger K et al. | β | 2013 | β |
| Duplications in RB1CC1 are associated with schizophrenia; identification in large European sample sets. | Degenhardt F et al. | β | 2013 | β |
| Evaluating rare variants in complex disorders using next-generation sequencing. | Ezewudo M et al. | β | 2013 | β |
| Family-based genome-wide copy number scan identifies five new genes of dyslexia involved in dendritic spinal plasticity. | Veerappa AM et al. | β | 2013 | β |
| Genes and environments in schizophrenia: The different pieces of a manifold puzzle. | RΓ©thelyi JM et al. | β | 2013 | β |
| Genetic architecture of skin and eye color in an African-European admixed population. | Beleza S et al. | β | 2013 | β |
| Genetic risk prediction: individualized variability in susceptibility to toxicants. | Nebert DW et al. | β | 2013 | β |
| Genetics of psychiatric disorders in the GWAS era: an update on schizophrenia. | Schwab SG et al. | β | 2013 | β |
| Genome-wide association study of schizophrenia using microsatellite markers in the Japanese population. | Shibata H et al. | β | 2013 | β |
| GLiMMPS: robust statistical model for regulatory variation of alternative splicing using RNA-seq data. | Zhao K et al. | β | 2013 | β |
| GStream: improving SNP and CNV coverage on genome-wide association studies. | Alonso A et al. | β | 2013 | β |
| Implication of a rare deletion at distal 16p11.2 in schizophrenia. | Guha S et al. | β | 2013 | β |
| Increased Rate of Sporadic and Recurrent Rare Genic Copy Number Variants in Parkinson's Disease Among Ashkenazi Jews. | Liu X et al. | β | 2013 | β |
| Investigation of NRXN1 deletions: clinical and molecular characterization. | Dabell MP et al. | β | 2013 | β |
| Molecular analysis of a deletion hotspot in the NRXN1 region reveals the involvement of short inverted repeats in deletion CNVs. | Chen X et al. | β | 2013 | β |
| Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literature. | BΓ©na F et al. | β | 2013 | β |
| NDE1 and NDEL1: twin neurodevelopmental proteins with similar 'nature' but different 'nurture'. | Bradshaw NJ et al. | β | 2013 | β |
| Polymorphisms in microRNA target sites influence susceptibility to schizophrenia by altering the binding of miRNAs to their targets. | Gong Y et al. | β | 2013 | β |
| Recent advances in the molecular genetics of epilepsy. | Hildebrand MS et al. | β | 2013 | β |
| Sequencing studies in human genetics: design and interpretation. | Goldstein DB et al. | β | 2013 | β |
| Structural, phylogenetic and docking studies of D-amino acid oxidase activator (DAOA), a candidate schizophrenia gene. | Sehgal SA et al. | β | 2013 | β |
| The effect of clozapine on mRNA expression for genes encoding G protein-coupled receptors and the protein components of clathrin-mediated endocytosis. | Sharp SI et al. | β | 2013 | β |
| The emerging spectrum of allelic variation in schizophrenia: current evidence and strategies for the identification and functional characterization of common and rare variants. | Mowry BJ et al. | β | 2013 | β |
| The impact of copy number deletions on general cognitive ability and ventricle size in patients with schizophrenia and healthy control subjects. | Yeo RA et al. | β | 2013 | β |
| Advanced paternal age increases the risk of schizophrenia and obsessive-compulsive disorder in a Chinese Han population. | Wu Y et al. | β | 2012 | β |
| A gene expression and systems pathway analysis of the effects of clozapine compared to haloperidol in the mouse brain implicates susceptibility genes for schizophrenia. | Rizig MA et al. | β | 2012 | β |
| Analysis of copy number variation in Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. | Swaminathan S et al. | β | 2012 | β |
| Analysis of copy number variation in Alzheimer's disease: the NIALOAD/ NCRAD Family Study. | Swaminathan S et al. | β | 2012 | β |
| An environmental analysis of genes associated with schizophrenia: hypoxia and vascular factors as interacting elements in the neurodevelopmental model. | Schmidt-Kastner R et al. | β | 2012 | β |
| A pilot study on collective effects of 22q13.31 deletions on gray matter concentration in schizophrenia. | Liu J et al. | β | 2012 | β |
| Association of the type 2 diabetes mellitus susceptibility gene, TCF7L2, with schizophrenia in an Arab-Israeli family sample. | Alkelai A et al. | β | 2012 | β |
| Autism risk factors: genes, environment, and gene-environment interactions. | Chaste P et al. | β | 2012 | β |
| Characterization of the neuropsychological phenotype of glycine N-methyltransferase-/- mice and evaluation of its responses to clozapine and sarcosine treatments. | Yang CP et al. | β | 2012 | β |
| Clinical applications of schizophrenia genetics: genetic diagnosis, risk, and counseling in the molecular era. | Costain G et al. | β | 2012 | β |
| Comprehensive pathway-based interrogation of genetic variations in the nucleotide excision DNA repair pathway and risk of bladder cancer. | Xing J et al. | β | 2012 | β |
| Contributions of the D-serine pathway to schizophrenia. | Labrie V et al. | β | 2012 | β |
| Detection and characterization of copy number variation in autism spectrum disorder. | Marshall CR et al. | β | 2012 | β |
| DISC1-binding proteins in neural development, signalling and schizophrenia. | Bradshaw NJ et al. | β | 2012 | β |
| Discovery of pod shatter-resistant associated SNPs by deep sequencing of a representative library followed by bulk segregant analysis in rapeseed. | Hu Z et al. | β | 2012 | β |
| Effect of genetic predisposition on blood lipid traits using cumulative risk assessment in the korean population. | Go MJ et al. | β | 2012 | β |
| Exome sequencing followed by large-scale genotyping fails to identify single rare variants of large effect in idiopathic generalized epilepsy. | Heinzen EL et al. | β | 2012 | β |
| Exome sequencing followed by large-scale genotyping suggests a limited role for moderately rare risk factors of strong effect in schizophrenia. | Need AC et al. | β | 2012 | β |
| Extracellular matrix abnormalities in schizophrenia. | Berretta S | β | 2012 | β |
| Gene Γ environment interaction by a longitudinal epigenome-wide association study (LEWAS) overcomes limitations of genome-wide association study (GWAS). | Lahiri DK et al. | β | 2012 | β |
| Genetic and cognitive windows into circuit mechanisms of psychiatric disease. | Arguello PA et al. | β | 2012 | β |
| Genetic polymorphisms in CYP2E1: association with schizophrenia susceptibility and risperidone response in the Chinese Han population. | Huo R et al. | β | 2012 | β |
| Genetic variations in the ADAMTS12 gene are associated with schizophrenia in Puerto Rican patients of Spanish descent. | Bespalova IN et al. | β | 2012 | β |
| Genome wide association studies (GWAS) and copy number variation (CNV) studies of the major psychoses: what have we learnt? | Lee KW et al. | β | 2012 | β |
| Genome-wide association studies in schizophrenia, and potential etiological and functional implications of their results. | HosΓ‘k L et al. | β | 2012 | β |
| Genome-wide association studies of schizophrenia: does bigger lead to better results? | Bergen SE et al. | β | 2012 | β |
| Genome-wide association study of serious blistering skin rash caused by drugs. | Shen Y et al. | β | 2012 | β |
| Genomewide pharmacogenetics of bisphosphonate-induced osteonecrosis of the jaw: the role of RBMS3. | Nicoletti P et al. | β | 2012 | β |
| Germline copy number variation and ovarian cancer survival. | Fridley BL et al. | β | 2012 | β |
| Human genetics of schizophrenia. | Claes S et al. | β | 2012 | β |
| Hypothesis-driven candidate genes for schizophrenia compared to genome-wide association results. | Collins AL et al. | β | 2012 | β |
| Immune system gene dysregulation in autism and schizophrenia. | Michel M et al. | β | 2012 | β |
| Imputation of rare variants in next-generation association studies. | Asimit JL et al. | β | 2012 | β |
| Investigating association of four gene regions (GABRB3, MAOB, PAH, and SLC6A4) with five symptoms in schizophrenia. | Sun J et al. | β | 2012 | β |
| Ion channels and schizophrenia: a gene set-based analytic approach to GWAS data for biological hypothesis testing. | Askland K et al. | β | 2012 | β |
| Is neuregulin 1 involved in determining cerebral volumes in schizophrenia? Preliminary results showing a decrease in superior temporal gyrus volume. | Tosato S et al. | β | 2012 | β |
| Isochromosome 13 in a patient with childhood-onset schizophrenia, ADHD, and motor tic disorder. | Graw SL et al. | β | 2012 | β |
| Meta-analysis indicates that common variants at the DISC1 locus are not associated with schizophrenia. | Mathieson I et al. | β | 2012 | β |
| Modelling the contribution of family history and variation in single nucleotide polymorphisms to risk of schizophrenia: a Danish national birth cohort-based study. | Agerbo E et al. | β | 2012 | β |
| Neuropathology of 16p13.11 deletion in epilepsy. | Liu JY et al. | β | 2012 | β |
| Next-generation sequencing: ready for the clinics? | Desai AN et al. | β | 2012 | β |
| Paradox of schizophrenia genetics: is a paradigm shift occurring? | Doi N et al. | β | 2012 | β |
| Phenotypic spectrum and genotype-phenotype correlations of NRXN1 exon deletions. | Schaaf CP et al. | β | 2012 | β |
| Proximal microdeletions and microduplications of 1q21.1 contribute to variable abnormal phenotypes. | Rosenfeld JA et al. | β | 2012 | β |
| Rare copy number variants in neuropsychiatric disorders: Specific phenotype or not? | Van Den Bossche MJ et al. | β | 2012 | β |
| Rare genomic deletions and duplications and their role in neurodevelopmental disorders. | Glessner JT et al. | β | 2012 | β |
| Recent genomic advances in schizophrenia. | Doherty JL et al. | β | 2012 | β |
| Schizophrenia: do all roads lead to dopamine or is this where they start? Evidence from two epidemiologically informed developmental rodent models. | Eyles D et al. | β | 2012 | β |
| Schizophrenia genetics: progress, at last. | Mulle JG | β | 2012 | β |
| Schizophrenia: maternal inheritance and heteroplasmy of mtDNA mutations. | Ichikawa T et al. | β | 2012 | β |
| Schizophrenia shows a unique metabolomics signature in plasma. | He Y et al. | β | 2012 | β |
| Statistical epistasis and progressive brain change in schizophrenia: an approach for examining the relationships between multiple genes. | Andreasen NC et al. | β | 2012 | β |
| Statistical tests for detecting rare variants using variance-stabilising transformations. | Wang K et al. | β | 2012 | β |
| Targeted pharmacogenetic analysis of antipsychotic response in the CATIE study. | Liu Q et al. | β | 2012 | β |
| The genetic architecture of schizophrenia: new mutations and emerging paradigms. | Rodriguez-Murillo L et al. | β | 2012 | β |
| The impact of genomics on pediatric research and medicine. | Connolly JJ et al. | β | 2012 | β |
| The mitosis and neurodevelopment proteins NDE1 and NDEL1 form dimers, tetramers, and polymers with a folded back structure in solution. | Soares DC et al. | β | 2012 | β |
| The role of neurexins in schizophrenia and autistic spectrum disorder. | Reichelt AC et al. | β | 2012 | β |
| What is complex about complex disorders? | Mitchell KJ | β | 2012 | β |
| ZNF804A and schizophrenia susceptibility in Asian populations. | Li M et al. | β | 2012 | β |
| A comparison of association methods correcting for population stratification in case-control studies. | Wu C et al. | β | 2011 | β |
| A critical review of the first 10 years of candidate gene-by-environment interaction research in psychiatry. | Duncan LE et al. | β | 2011 | β |
| ADAMTSL3 as a candidate gene for schizophrenia: gene sequencing and ultra-high density association analysis by imputation. | Dow DJ et al. | β | 2011 | β |
| A multilevel model to address batch effects in copy number estimation using SNP arrays. | Scharpf RB et al. | β | 2011 | β |
| Analysis of genetic deletions and duplications in the University College London bipolar disorder case control sample. | McQuillin A et al. | β | 2011 | β |
| A Novel Microduplication in the Neurodevelopmental Gene SRGAP3 That Segregates with Psychotic Illness in the Family of a COS Proband. | Wilson NK et al. | β | 2011 | β |
| A pipeline for copy number variation detection based on principal component analysis. | Chen J et al. | β | 2011 | β |
| A scan statistic to extract causal gene clusters from case-control genome-wide rare CNV data. | Nishiyama T et al. | β | 2011 | β |
| Assessment of copy number variation using the Illumina Infinium 1M SNP-array: a comparison of methodological approaches in the Spanish Bladder Cancer/EPICURO study. | Marenne G et al. | β | 2011 | β |
| Association of FAS, a TNF-Ξ± receptor gene, with treatment resistant schizophrenia. | Jia P et al. | β | 2011 | β |
| Association study of RELN polymorphisms with schizophrenia in Han Chinese population. | Li W et al. | β | 2011 | β |
| Autosome-wide copy number variation association analysis for rheumatoid arthritis using the WTCCC high-density SNP genotype data. | Uddin M et al. | β | 2011 | β |
| Clustered coding variants in the glutamate receptor complexes of individuals with schizophrenia and bipolar disorder. | Frank RA et al. | β | 2011 | β |
| Comparative linkage meta-analysis reveals regionally-distinct, disparate genetic architectures: application to bipolar disorder and schizophrenia. | Tang B et al. | β | 2011 | β |
| Comprehensive gene-based association study of a chromosome 20 linked region implicates novel risk loci for depressive symptoms in psychotic illness. | Bigdeli TB et al. | β | 2011 | β |
| Copy number variants: a new molecular frontier in clinical psychiatry. | Moreno-De-Luca D et al. | β | 2011 | β |
| Copy number variants for schizophrenia and related psychotic disorders in Oceanic Palau: risk and transmission in extended pedigrees. | Melhem N et al. | β | 2011 | β |
| Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. | Levinson DF et al. | β | 2011 | β |
| Copy number variants of schizophrenia susceptibility loci are associated with a spectrum of speech and developmental delays and behavior problems. | Sahoo T et al. | β | 2011 | β |
| Copy number variation in familial Parkinson disease. | Pankratz N et al. | β | 2011 | β |
| Copy number variations of chromosome 16p13.1 region associated with schizophrenia. | Ingason A et al. | β | 2011 | β |
| Evidence for a SULT4A1 haplotype correlating with baseline psychopathology and atypical antipsychotic response. | Ramsey TL et al. | β | 2011 | β |
| Evidence of sex-modulated association of ZNF804A with schizophrenia. | Zhang F et al. | β | 2011 | β |
| Expanding the range of ZNF804A variants conferring risk of psychosis. | Steinberg S et al. | β | 2011 | β |
| Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. | Williams HJ et al. | β | 2011 | β |
| Following the genes: a framework for animal modeling of psychiatric disorders. | Mitchell KJ et al. | β | 2011 | β |
| Genetic association studies of antioxidant pathway genes and schizophrenia. | Chowdari KV et al. | β | 2011 | β |
| Genetic regulation of Nrxn1 [corrected] expression: an integrative cross-species analysis of schizophrenia candidate genes. | Mozhui K et al. | β | 2011 | β |
| Genetics in psychiatry: are the promises met? | Bondy B | β | 2011 | β |
| Genetics of schizophrenia: new findings and challenges. | Gejman PV et al. | β | 2011 | β |
| Genome arrays for the detection of copy number variations in idiopathic mental retardation, idiopathic generalized epilepsy and neuropsychiatric disorders: lessons for diagnostic workflow and research. | Hochstenbach R et al. | β | 2011 | β |
| Genome-wide analysis shows increased frequency of copy number variation deletions in Dutch schizophrenia patients. | Buizer-Voskamp JE et al. | β | 2011 | β |
| Genome-wide investigation of rare structural variants identifies VIPR2 as a new candidate gene for schizophrenia. | Nieratschker V et al. | β | 2011 | β |
| Genome-wide searches for bipolar disorder genes. | Alsabban S et al. | β | 2011 | β |
| Genomic Copy Number Analysis in Alzheimer's Disease and Mild Cognitive Impairment: An ADNI Study. | Swaminathan S et al. | β | 2011 | β |
| Human copy number variation and complex genetic disease. | Girirajan S et al. | β | 2011 | β |
| Inherited balanced translocation t(9;17)(q33.2;q25.3) concomitant with a 16p13.1 duplication in a patient with schizophrenia. | Fullston T et al. | β | 2011 | β |
| Maternally derived microduplications at 15q11-q13: implication of imprinted genes in psychotic illness. | Ingason A et al. | β | 2011 | β |
| Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and age of onset in schizophrenia: a combined analysis of independent samples. | Saetre P et al. | β | 2011 | β |
| Neurexin-1 and frontal lobe white matter: an overlapping intermediate phenotype for schizophrenia and autism spectrum disorders. | Voineskos AN et al. | β | 2011 | β |
| Ontogenetic de novo copy number variations (CNVs) as a source of genetic individuality: studies on two families with MZD twins for schizophrenia. | Maiti S et al. | β | 2011 | β |
| PKA phosphorylation of NDE1 is DISC1/PDE4 dependent and modulates its interaction with LIS1 and NDEL1. | Bradshaw NJ et al. | β | 2011 | β |
| Rare copy number deletions predict individual variation in human brain metabolite concentrations in individuals with alcohol use disorders. | Yeo RA et al. | β | 2011 | β |
| Rare copy number deletions predict individual variation in intelligence. | Yeo RA et al. | β | 2011 | β |
| RELN rs7341475 and schizophrenia risk: confusing, yet somehow intriguing. | Tost H et al. | β | 2011 | β |
| Resequencing and follow-up of neurexin 1 (NRXN1) in schizophrenia patients. | MΓΌhleisen TW et al. | β | 2011 | β |
| Rethinking the genetic architecture of schizophrenia. | Mitchell KJ et al. | β | 2011 | β |
| RNA-Seq of human neurons derived from iPS cells reveals candidate long non-coding RNAs involved in neurogenesis and neuropsychiatric disorders. | Lin M et al. | β | 2011 | β |
| Schizophrenia genetics: where next? | Kim Y et al. | β | 2011 | β |
| SgD-CNV, a database for common and rare copy number variants in three Asian populations. | Xu H et al. | β | 2011 | β |
| The genetic effect of copy number variations on the risk of type 2 diabetes in a Korean population. | Bae JS et al. | β | 2011 | β |
| The genetics of neurodevelopmental disease. | Mitchell KJ | β | 2011 | β |
| The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: assessing courses, types and time stability of diagnostic classification. | MΓΆller HJ et al. | β | 2011 | β |
| The schizophrenia risk allele C of the TCF4 rs9960767 polymorphism disrupts sensorimotor gating in schizophrenia spectrum and healthy volunteers. | Quednow BB et al. | β | 2011 | β |
| Turner syndrome and sexual differentiation of the brain: implications for understanding male-biased neurodevelopmental disorders. | Knickmeyer RC et al. | β | 2011 | β |
| Approaches for evaluating rare polymorphisms in genetic association studies. | Li Q et al. | β | 2010 | β |
| Association analyses between brain-expressed fatty-acid binding protein (FABP) genes and schizophrenia and bipolar disorder. | Iwayama Y et al. | β | 2010 | β |
| Association study of ubiquitin-specific peptidase 46 (USP46) with bipolar disorder and schizophrenia in a Japanese population. | Kushima I et al. | β | 2010 | β |
| Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls. | Nicodemus KK et al. | β | 2010 | β |
| Cognition in mouse models of schizophrenia susceptibility genes. | Arguello PA et al. | β | 2010 | β |
| Common promoter variants of the NDUFV2 gene do not confer susceptibility to schizophrenia in Han Chinese. | Zhang W et al. | β | 2010 | β |
| Common variants in the TPH1 and TPH2 regions are not associated with persistent ADHD in a combined sample of 1,636 adult cases and 1,923 controls from four European populations. | Johansson S et al. | β | 2010 | β |
| Copy number variation in schizophrenia in the Japanese population. | Ikeda M et al. | β | 2010 | β |
| Copy number variation of the SELENBP1 gene in schizophrenia. | Amar S et al. | β | 2010 | β |
| Copy number variations in schizophrenia: critical review and new perspectives on concepts of genetics and disease. | Bassett AS et al. | β | 2010 | β |
| Correction of Copy Number Variation Data Using Principal Component Analysis. | Chen J et al. | β | 2010 | β |
| Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models. | Watanabe Y et al. | β | 2010 | β |
| Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders. | Ching MS et al. | β | 2010 | β |
| Ethical challenges in genotype-driven research recruitment. | Beskow LM et al. | β | 2010 | β |
| Evidence for association of the GLI2 gene with tardive dyskinesia in patients with chronic schizophrenia. | Greenbaum L et al. | β | 2010 | β |
| Evidence of statistical epistasis between DISC1, CIT and NDEL1 impacting risk for schizophrenia: biological validation with functional neuroimaging. | Nicodemus KK et al. | β | 2010 | β |
| Evolution in health and medicine Sackler colloquium: Comparative genomics of autism and schizophrenia. | Crespi B et al. | β | 2010 | β |
| Evolution in health and medicine Sackler colloquium: Consanguinity, human evolution, and complex diseases. | Bittles AH et al. | β | 2010 | β |
| Failure to find an association between myosin heavy chain 9, non-muscle (MYH9) and schizophrenia: a three-stage case-control association study. | Amagane H et al. | β | 2010 | β |
| Fine mapping of AHI1 as a schizophrenia susceptibility gene: from association to evolutionary evidence. | Torri F et al. | β | 2010 | β |
| Further investigation of the association between rs7341475 and rs17746501 and schizophrenia. | Ben-David E et al. | β | 2010 | β |
| Genetics in schizophrenia: where are we and what next? | Tiwari AK et al. | β | 2010 | β |
| Genome-wide approaches to schizophrenia. | Duan J et al. | β | 2010 | β |
| Genome-wide association studies: a powerful tool for neurogenomics. | Cowperthwaite MC et al. | β | 2010 | β |
| Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies. | Mefford HC et al. | β | 2010 | β |
| Genome-wide scan of copy number variation in late-onset Alzheimer's disease. | Heinzen EL et al. | β | 2010 | β |
| Identification of genome-wide copy number variations and a family-based association study of Avellino corneal dystrophy. | Bae JS et al. | β | 2010 | β |
| Large copy-number variations are enriched in cases with moderate to extreme obesity. | Wang K et al. | β | 2010 | β |
| Microdeletions of 3q29 confer high risk for schizophrenia. | Mulle JG et al. | β | 2010 | β |
| MicroRNA dysregulation in psychiatric disease. | Miller BH et al. | β | 2010 | β |
| Narrowing the boundaries of the genetic architecture of schizophrenia. | Wray NR et al. | β | 2010 | β |
| New copy number variations in schizophrenia. | Magri C et al. | β | 2010 | β |
| New findings in the genetics of major psychoses. | NΓΆthen MM et al. | β | 2010 | β |
| New Genetic Findings in Schizophrenia: Is there Still Room for the Dopamine Hypothesis of Schizophrenia? | Nieratschker V et al. | β | 2010 | β |
| No association between AKT1 polymorphism and schizophrenia: a case-control study in a Korean population and a meta-analysis. | Lee KY et al. | β | 2010 | β |
| Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy. | Gervasini G et al. | β | 2010 | β |
| Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections. | Domenici E et al. | β | 2010 | β |
| Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. | Heinzen EL et al. | β | 2010 | β |
| Rare NRXN1 promoter variants in patients with schizophrenia. | Shah AK et al. | β | 2010 | β |
| Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. | de Kovel CG et al. | β | 2010 | β |
| Rethinking schizophrenia. | Insel TR | β | 2010 | β |
| REVIEW: Genome-wide findings in schizophrenia and the role of gene-environment interplay. | Van Winkel R et al. | β | 2010 | β |
| Sex-specific association of the Reelin gene with bipolar disorder. | Goes FS et al. | β | 2010 | β |
| Strong synaptic transmission impact by copy number variations in schizophrenia. | Glessner JT et al. | β | 2010 | β |
| The application of massively parallel sequencing technologies in diagnostics. | Dahl A et al. | β | 2010 | β |
| The role of copy number variation in schizophrenia. | Kirov G | β | 2010 | β |
| The role of genetics in the etiology of schizophrenia. | Gejman PV et al. | β | 2010 | β |
| Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease. | GΓ³mez Ravetti M et al. | β | 2010 | β |
| Uncovering the roles of rare variants in common disease through whole-genome sequencing. | Cirulli ET et al. | β | 2010 | β |
| Whole genome association studies in complex diseases: where do we stand? | Need AC et al. | β | 2010 | β |
| A genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB. | Need AC et al. | β | 2009 | β |
| Autism genetics: emerging data from genome-wide copy-number and single nucleotide polymorphism scans. | Weiss LA | β | 2009 | β |
| Common variants in polygenic schizophrenia. | Glessner JT et al. | β | 2009 | β |
| Copy-number variants in neurodevelopmental disorders: promises and challenges. | Merikangas AK et al. | β | 2009 | β |
| DUF1220 domains, cognitive disease, and human brain evolution. | Dumas L et al. | β | 2009 | β |
| Evidence for the association of the DAOA (G72) gene with schizophrenia and bipolar disorder but not for the association of the DAO gene with schizophrenia. | Bass NJ et al. | β | 2009 | β |
| Genetic overlap between autism, schizophrenia and bipolar disorder. | Carroll LS et al. | β | 2009 | β |
| Genetics of complex neurological disease: challenges and opportunities for modeling epilepsy in mice and rats. | Frankel WN | β | 2009 | β |
| Genetics of psychosis; insights from views across the genome. | O'Donovan MC et al. | β | 2009 | β |
| Genomewide association studies and human disease. | Hardy J et al. | β | 2009 | β |
| Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. | van Es MA et al. | β | 2009 | β |
| Genotype to phenotype-discovery and characterization of novel genomic disorders in a "genotype-first" era. | Mefford HC | β | 2009 | β |
| Linkage and association studies of anxiety disorders. | Hamilton SP | β | 2009 | β |
| Massively parallel sequencing: the next big thing in genetic medicine. | Tucker T et al. | β | 2009 | β |
| Neurexin 1 (NRXN1) deletions in schizophrenia. | Kirov G et al. | β | 2009 | β |
| Next generation disparities in human genomics: concerns and remedies. | Need AC et al. | β | 2009 | β |
| Persistence criteria for susceptibility genes for schizophrenia: a discussion from an evolutionary viewpoint. | Doi N et al. | β | 2009 | β |
| Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. | Sebat J et al. | β | 2009 | β |
| Searching genetic risk factors for schizophrenia and bipolar disorder: learn from the past and back to the future. | Alaerts M et al. | β | 2009 | β |
| The intersection of pharmacology, imaging, and genetics in the development of personalized medicine. | Gerretsen P et al. | β | 2009 | β |